Agios Pharma (AGIO) PT Raised to $83 at Oppenheimer on 2Q Report; 'Strong Clinical Update'

August 8, 2017 11:20 AM

Oppenheimer raised its price target on Agios Pharma (NASDAQ: AGIO) to $83.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found